Cargando…

Evaluation of Effectiveness and Tolerability of Fondaparinux in the Management of Symptomatic Acute Coronary Syndrome: A Real-World Evidence-Based Study on an Indian Population

INTRODUCTION: Fondaparinux is a low molecular weight heparin anticoagulant used to manage the full spectrum of acute coronary syndrome (ACS) patients and has proved its efficacy and safety in multiple clinical trials. However, there are limited data available showing whether the same results could b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dalal, Jamshed, Mohan, J. C., Sathe, Sunil, Kumar, A. Sreenivas, Hiremath, Jagdish, Khan, Mohammed Yunus, Gaurav, Kumar, Mane, Amey, Pandit, Sucheta, Meel, Bhavesh, Subramaniyan, Anand
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933594/ https://www.ncbi.nlm.nih.gov/pubmed/35138595 http://dx.doi.org/10.1007/s40119-022-00253-x

Ejemplares similares

Effectiveness and Tolerability of Fondaparinux vs Enoxaparin in a Population of Indian Patients with Symptomatic Deep Vein Thrombosis: A Retrospective Real-World Study
por: Ramakrishna, Pinjala, et al.
Publicado: (2021)

Fondaparinux: A cornerstone drug in acute coronary syndromes
por: Khan, Mohammed Yunus, et al.
Publicado: (2022)

Effectiveness of Amlodipine on Blood Pressure Control in Hypertensive Patients in India: A Real-World, Retrospective Study from Electronic Medical Records
por: Khan, Mohammed Yunus, et al.
Publicado: (2020)

Effectiveness and Effect on Renal Parameters of Amlodipine vs. Other Dihydropyridine Calcium Channel Blockers in Patients with Essential Hypertension: Retrospective Observational Study Based on Real-World Evidence from Electronic Medical Records
por: Jadhav, Uday, et al.
Publicado: (2021)

Clinical Decision Pathway for the Use of Fondaparinux in the Management of Acute Coronary Syndrome (ACS) in Hospitals with and Without Catheter Laboratories: An Expert Opinion from India
por: Ray, Saumitra, et al.
Publicado: (2023)

Electronic medical records-based retrospective, longitudinal, observational study to understand the patient management of benign prostatic hyperplasia with alpha-blockers monotherapy in Indian population
por: Gupta, Rahul, et al.
Publicado: (2023)

The Fondaparinux Paradox: Fondaparinux-Related Heparin-induced Thrombocytopenia
por: Vadi, Sonali, et al.
Publicado: (2018)

Effectiveness of Telmisartan on Blood Pressure Control in Hypertensive Patients in India: A Real-World Retrospective Study from Electronic Medical Records
por: Khan, Mohammed Yunus, et al.
Publicado: (2021)

A Retrospective, Observational, EMR-Based Real-World Evidence Study to Assess the Incidence of Pedal Edema in Essential Hypertensive Patients on Amlodipine or Cilnidipine
por: Dalal, Jamshed, et al.
Publicado: (2022)

The clinical course of symptomatic deep vein thrombosis after 3 months of anticoagulant therapy using fondaparinux/edoxaban or fondaparinux/vitamin K antagonist
por: Shimizu, Kazuhiro, et al.
Publicado: (2018)

Practical Recommendations for the Use of Angiotensin Receptor-Neprilysin Inhibitors (ARNI) in Heart Failure: Insights from Indian Cardiologists
por: Dalal, Jamshed, et al.
Publicado: (2023)

Fondaparinux-associated Thrombocytopenia
por: Malik, Jahanzeb, et al.
Publicado: (2021)

The Indian Consensus Document on cardiac biomarker
por: Satyamurthy, I., et al.
Publicado: (2014)

When Will Fondaparinux Induce Thrombocytopenia?
por: Chen, Li-Yu, et al.
Publicado: (2022)

Design and Synthesis of Neutralizable Fondaparinux
por: Zhang, Liangwei, et al.
Publicado: (2022)

S-Amlodipine: An Isomer with Difference—Time to Shift from Racemic Amlodipine
por: Dalal, Jamshed, et al.
Publicado: (2018)

Use of Fondaparinux Following Elective Lumbar Spine Surgery Is Associated With a Reduction in Symptomatic Venous Thromboembolism
por: Fourman, Mitchell S., et al.
Publicado: (2019)

Management of acute coronary syndromes with fondaparinux
por: Wienbergen, Harm, et al.
Publicado: (2007)

Thromboelastographic monitoring of fondaparinux in surgical patients
por: Martinez, B, et al.
Publicado: (2013)

Failure of Fondaparinux in Autoimmune Heparin-Induced Thrombocytopenia
por: Sartori, Michelangelo, et al.
Publicado: (2020)

Probable fondaparinux-associated bullous hemorrhagic dermatosis
por: Lovatt, Catherine Anne, et al.
Publicado: (2021)

Suspecting and diagnosing transthyretin amyloid cardiomyopathy (ATTR-CM) in India: An Indian expert consensus
por: Chander Mohan, Jagdish, et al.
Publicado: (2022)

Demographic Profile and Prescribing Patterns of Anti-epileptic Drugs in Indian Epilepsy Patients: Electronic Medical Record-Based Nation-Wide Retrospective Cohort Study
por: Bansal, Atmaram, et al.
Publicado: (2022)

An Evidence-Based Retrospective Study for the Management of Acid Peptic Disease With Omeprazole, a Proton Pump Inhibitor, in Indian Patients With Type 2 Diabetes Mellitus (PRIDE-1)
por: Saboo, Bharat, et al.
Publicado: (2022)

A Real-World Perspective of Co-amoxiclav Prescription Pattern With Probiotics for Pediatric Patients With Respiratory Tract Infections: Results of Quantitative and Qualitative Approach in Indian Outpatient Settings
por: Choudhury, Jaydeep, et al.
Publicado: (2023)

Fondaparinux: Should It Be Studied in Patients with COVID-19 Disease?
por: Marongiu, Francesco, et al.
Publicado: (2020)

Fondaparinux and bleeding risk in COVID-19: unsolved question
por: Russo, Vincenzo, et al.
Publicado: (2021)

Dermatose bulleuse hémorragique probablement associée au fondaparinux
por: Lovatt, Catherine Anne, et al.
Publicado: (2021)

Symptomatic Primary Ovarian Leiomyoma in a Postmenopausal Woman: A Rare Entity
por: Meel, Mukta, et al.
Publicado: (2020)

ACPTI study: Being positive in a negative situation is not naivety – Trimetazidine still has role in symptomatic CAD patients
por: Dalal, Jamshed, et al.
Publicado: (2021)

Fondaparinux in the management of patients with ST-elevation acute myocardial infarction
por: Turpie, Alexander GG
Publicado: (2006)

Fondaparinux–Associated Rectus Sheath Hematoma: Skating on Thin Ice
por: Sabanis, Nikolaos, et al.
Publicado: (2020)

The use of fondaparinux and rituximab for recurrent thrombotic events in antiphospholipid syndrome
por: Sayar, Zara, et al.
Publicado: (2022)

Choosing between Enoxaparin and Fondaparinux for the management of patients with acute coronary syndrome: A systematic review and meta-analysis
por: Bundhun, Pravesh Kumar, et al.
Publicado: (2017)

Fondaparinux and acute coronary syndromes: update on the OASIS 5–6 studies
por: Schiele, François
Publicado: (2010)

Oral fondaparinux: use of lipid nanocapsules as nanocarriers and in vivo pharmacokinetic study
por: Ramadan, Alyaa, et al.
Publicado: (2011)

Spontaneous acute subdural hematoma due to fondaparinux: Report of two cases
por: Fryburg, Karsten, et al.
Publicado: (2011)

Fondaparinux: another potential treatment for heparin-induced thrombocytopenia type II?
por: Honore, Patrick M., et al.
Publicado: (2016)

Fondaparinux vs warfarin for the treatment of unsuspected pulmonary embolism in cancer patients
por: Amato, Bruno, et al.
Publicado: (2016)

Fondaparinux vs warfarin for the treatment of unsuspected pulmonary embolism in cancer patients
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_o3pjb7srechl3m7mgjgf1fcsbf